Are Müller glial cells gatekeepers of neuroprotection and regeneration in age-related macular degeneration? Unraveling their roles in pathophysiology and therapeutic innovation

Progress in Retinal and Eye Research · Published 2026-04-14 · DOI 10.1016/j.preteyeres.2026.101471

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.preteyeres.2026.101471

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Surgical management of myopic traction maculopathy; expert perspectives from the myopia society · Progress in Retinal and Eye Research · 2026 · Same journal
• Eye–brain axis: Ocular and visual pathophysiology as driver and therapeutic target across the mood disorder trajectory · Progress in Retinal and Eye Research · 2026 · Same journal
• Multiple evanescent white dot syndrome: Typical, atypical, and secondary variants · Progress in Retinal and Eye Research · 2025 · Same journal
• Introducing the blood-tear barrier: Structure, function, and disruption in ocular surface homeostasis · Progress in Retinal and Eye Research · 2026 · Same journal
• Lens aging and disease: Molecular mechanisms, functional consequences, and pharmacological implications · Progress in Retinal and Eye Research · 2026 · Same journal
• Drug Delivery Across the Blood-Retinal Barrier: Biological Gateways for Posterior Segment Therapy · Progress in Retinal and Eye Research · 2026 · Same journal
• Macular fibrosis secondary to neovascular age-related macular degeneration: from clinic to biology · Progress in Retinal and Eye Research · 2026 · Same journal
• Optical coherence tomography in pediatric ophthalmology: Insights into ocular development, diagnosis and management of eye diseases · Progress in Retinal and Eye Research · 2026 · Same journal
• Current progress in research on ocular injury caused by exposure to vesicants · Progress in Retinal and Eye Research · 2025 · Same journal
• Diabetic retinal disease cure accelerator: Modernizing staging and endpoints · Progress in Retinal and Eye Research · 2026 · Same journal